Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules. Barrow RT, Healey JF, Gailani D, Scandella D, Lollar P (2000) Blood 95: 564-8 Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. Gailani D, Broze GJ (1993) Blood 82: 813-9 Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Puy C, Tucker EI, Matafonov A, Cheng Q, Zientek KD, Gailani D, Gruber A, McCarty OJ (2015) Blood 125: 1488-96 Detection of factor X activation in humans. Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger JJ, Rosenberg RD (1989) Blood 74: 2007-15 Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents. Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Harrell S, Rubinstein SM, Hall R, Wyatt H, Piazza G (2020) Br J Haematol 190: 555-561 Kinetic intermediates in prothrombin activation. Bovine prethrombin 1 conversion to thrombin by factor X. Carlisle TL, Bock PE, Jackson CM (1990) J Biol Chem 265: 22044-55 Role of proexosite I in factor Va-dependent substrate interactions of prothrombin activation. Anderson PJ, Nesset A, Dharmawardana KR, Bock PE (2000) J Biol Chem 275: 16435-42 Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes. Newell-Caito JL, Laha M, Tharp AC, Creamer JI, Xu H, Maddur AA, Tans G, Bock PE (2011) J Biol Chem 286: 38286-38297 The role of thrombin exosites I and II in the activation of human coagulation factor V. Segers K, Dahlbäck B, Bock PE, Tans G, Rosing J, Nicolaes GA (2007) J Biol Chem 282: 33915-24 Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase. Hacisalihoglu A, Panizzi P, Bock PE, Camire RM, Krishnaswamy S (2007) J Biol Chem 282: 32974-82 Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin. Anderson PJ, Nesset A, Bock PE (2003) J Biol Chem 278: 44482-8 Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. Berny MA, Munnix IC, Auger JM, Schols SE, Cosemans JM, Panizzi P, Bock PE, Watson SP, McCarty OJ, Heemskerk JW (2010) PLoS One 5: e10415 Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Spitznagel E, Cox JL, Lappas DG (1994) J Thorac Cardiovasc Surg 108: 1076-82 Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements. Despotis GJ, Joist JH, Goodnough LT, Santoro SA, Spitznagel E (1997) J Thorac Cardiovasc Surg 113: 611-3 Activation of proteinase-activated receptor-2 in mesothelial cells induces pleural inflammation. Lee YC, Knight DA, Lane KB, Cheng DS, Koay MA, Teixeira LR, Nesbitt JC, Chambers RC, Thompson PJ, Light RW (2005) Am J Physiol Lung Cell Mol Physiol 288: L734-40 Comparative study of the active site caging of serine proteases: thrombin and factor Xa. Thuring JW, Li H, Porter NA (2002) Biochemistry 41: 2002-13 Isolation of human blood coagulation alpha-factor Xa by soybean trypsin inhibitor-sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate. Bock PE, Craig PA, Olson ST, Singh P (1989) Arch Biochem Biophys 273: 375-88
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.